BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 18723234)

  • 1. The use of intra-coronary optical coherence tomography for the assessment of sirolimus-eluting stent fracture.
    Barlis P; Sianos G; Ferrante G; Del Furia F; D'Souza S; Di Mario C
    Int J Cardiol; 2009 Jul; 136(1):e16-20. PubMed ID: 18723234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fracture of a paclitaxol-eluting stent implanted for in-stent restenosis at the site of sirolimus-eluting stent fracture.
    Watanabe T; Tamura A; Miyamoto K; Kadota J
    Int J Cardiol; 2010 Apr; 140(1):e12-3. PubMed ID: 19059662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Very late stent thrombosis after sirolimus-eluting stent implantation observed using optical coherence tomography and coronary angioscopy.
    Ikenaga H; Dai K; Ishihara M
    J Invasive Cardiol; 2010 Nov; 22(11):557-8. PubMed ID: 21041855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and clinical impact of fracture of drug-eluting stents widely used in current clinical practice: comparison with initial platform of sirolimus-eluting stent.
    Park MW; Chang K; Her SH; Lee JM; Choi YS; Kim DB; Kim PJ; Cho JS; Choi MS; Baek JY; Park CS; Yoon SG; Chung WS; Seung KB
    J Cardiol; 2012 Sep; 60(3):215-21. PubMed ID: 22890068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical "vacuum" inside of neoatherosclerosis long term after DES implantation: insights from optical coherence tomography.
    Granata F; Attizzani GF; Tartaglione D; Cappelli Bigazzi M; Bianchi R; Varricchio A; Russo MG; Calabrò P
    Int J Cardiol; 2015 Nov; 199():221-2. PubMed ID: 26209822
    [No Abstract]   [Full Text] [Related]  

  • 7. Serial assessment of vessel interactions after drug-eluting stent implantation in unprotected distal left main coronary artery disease using frequency-domain optical coherence tomography.
    Fujino Y; Attizzani GF; Bezerra HG; Wang W; Tahara S; Yamamoto H; Chamie D; Kanaya T; Mehanna E; Takagi K; Nakamura S; Costa MA
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1035-45. PubMed ID: 24156964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved vascular healing after the successful treatment of very late sirolimus-eluting stent thrombosis with a bare metal stent implantation - A serial optical coherence tomography study.
    Bouki KP; Vlad D; Riga M; Stergiouli I; Toutouzas KP
    Hellenic J Cardiol; 2016; 57(2):129-33. PubMed ID: 27445030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sirolimus-eluting stent fractures leading to restenosis in cardiac allograft vasculopathy.
    Cilingiroglu M; Chilakapati V; Dunlap S; Leesar MA
    Cardiovasc Revasc Med; 2010; 11(2):120-3. PubMed ID: 20347805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents.
    Guagliumi G; Musumeci G; Sirbu V; Bezerra HG; Suzuki N; Fiocca L; Matiashvili A; Lortkipanidze N; Trivisonno A; Valsecchi O; Biondi-Zoccai G; Costa MA;
    JACC Cardiovasc Interv; 2010 May; 3(5):531-9. PubMed ID: 20488410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-year clinical and angiographic outcomes from a randomized trial of polymer-free dual drug-eluting stents versus polymer-based Cypher and Endeavor [corrected] drug-eluting stents.
    Byrne RA; Kastrati A; Tiroch K; Schulz S; Pache J; Pinieck S; Massberg S; Seyfarth M; Laugwitz KL; Birkmeier KA; Schömig A; Mehilli J;
    J Am Coll Cardiol; 2010 Jun; 55(23):2536-43. PubMed ID: 20417052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences between first-generation and second-generation drug-eluting stent regarding in-stent neoatherosclerosis characteristics: an optical coherence tomography analysis.
    Kobayashi N; Ito Y; Yamawaki M; Araki M; Sakai T; Obokata M; Sakamoto Y; Mori S; Tsutsumi M; Nauchi M; Honda Y; Tokuda T; Makino K; Shirai S; Hirano K
    Int J Cardiovasc Imaging; 2018 Oct; 34(10):1521-1528. PubMed ID: 29785558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiographic patterns of restenosis with 2nd generation drug-eluting stent: comparative analysis from a 10-year single-center experience .
    Lee S; Yoon CH; Oh IY; Suh JW; Cho YS; Cho GY; Chae IH; Choi DJ; Youn TJ
    Int Heart J; 2015; 56(1):6-12. PubMed ID: 25503656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary stent strut fracture after drug-eluting stent implantation: a newly recognized complication.
    Celik T; Iyisoy A; Dogru MT; Isik E
    Int J Cardiol; 2009 Feb; 132(1):121-2. PubMed ID: 17692950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neointimal hyperplasia after sirolimus-eluting and paclitaxel-eluting stent implantation in diabetic patients: the Randomized Diabetes and Drug-Eluting Stent (DiabeDES) Intravascular Ultrasound Trial.
    Jensen LO; Maeng M; Thayssen P; Christiansen EH; Hansen KN; Galloe A; Kelbaek H; Lassen JF; Thuesen L
    Eur Heart J; 2008 Nov; 29(22):2733-41. PubMed ID: 18832385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiographically silent very late stent thrombosis detected by optical coherence tomography in association with peri-stent staining and multiple interstrut cavities.
    Cassar A; Gulati R; Matsuo Y; Bresnahan JF; Prasad A
    Eur Heart J Cardiovasc Imaging; 2013 Jun; 14(6):603. PubMed ID: 23258315
    [No Abstract]   [Full Text] [Related]  

  • 17. Multiple stent strut fracture-induced restenosis in a diffuse long lesion treated with overlapping heterogeneous drug-eluting stent.
    Kang WC; Moon C; Ahn TH; Shin EK
    Int J Cardiol; 2008 Oct; 130(1):e30-3. PubMed ID: 17889952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Very late thrombosis of sirolimus-eluting stent due to late malapposition: serial observations with optical coherence tomography.
    Sawada T; Shite J; Shinke T; Tanino Y; Ogasawara D; Kawamori H; Kato H; Miyoshi N; Yoshino N; Hirata K
    J Cardiol; 2008 Dec; 52(3):290-5. PubMed ID: 19027609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
    Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
    EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Association between stent fracture and restenosis after drug-eluting stent implantation].
    Tian F; Chen YD; Sun ZJ; Liu CF; Yang TS; Song XT
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Jan; 37(1):35-8. PubMed ID: 19671349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.